Search - tctmd.com

Displaying 301 - 320 of 1282

Sort: Relevancy | Date

Presentation NY Valves 2024

Impact of Tricuspid Transcatheter Edge to Edge Repair on Right Ventricular Function

Presenter: Parasuram Krishnamoorthy

June 05, 2024

Presentation NY Valves 2024

Diagnostic Imaging and Preparation for T-TEER

Presenter: Christian Besler

June 05, 2024

Presentation NY Valves 2024

Transcatheter Aortic Valve Replacement Reduces Tricuspid Regurgitation Severity at 30 Days – Insights From a Large Academic Medical Center Study

Presenter: Shreeya Shabari

June 05, 2024

Presentation NY Valves 2024

Progression of Mitral Regurgitation Severity After Transcatheter Tricuspid Valve Replacement

Presenter: Melissa Yen Yen Moey

June 05, 2024

Presentation NY Valves 2024

Experience-Based Lessons Learned from Real World T-TEER Cases

Presenter: Jörg Hausleiter

June 05, 2024

News Conference News EuroPCR 2024

Young, Low-risk Patients Fare Well With TAVI, but Beware the Bicuspids

Michael O'Riordan

May 15, 2024

Presentation EuroPCR 2024

First TAVI vs. SAVR randomised trial in younger low-risk patients with severe tricuspid or bicuspid aortic valve stenosis - results from NOTION-2

Presenter: Ole De Backer

May 15, 2024

News Daily News

STS Releases New Risk-Prediction Tools for Emerging Surgical Scenarios

Yael L. Maxwell

May 01, 2024

Another Win for TAVI in Low-to-Intermediate Risk Patients

News Conference News ACC 2024

Another Win for TAVI in Patients at Low-to-Intermediate Risk: DEDICATE-DZHK6

Yael L. Maxwell

April 08, 2024

News Daily News

FDA Approves TriClip TEER Device for Tricuspid Repair

L.A. McKeown

April 02, 2024

News Opinion Off Script

Evoque and Patisiran: A Tale of Two Regulatory Journeys

Sanjay Kaul, MD

March 29, 2024

News Daily News

First-Ever Performance, Quality Metrics Created for Valvular and Structural Disease

Michael O'Riordan

March 20, 2024

News Conference News THT 2024

Debating the Role of T-TEER in the Sickest Patients

Michael O'Riordan

March 05, 2024

Presentation THT Abstracts 2024

Right Ventricular-Pulmonary Arterial Coupling in Tricuspid Regurgitation†and Implications of Transcatheter Tricuspid Valve Repair 2013 A Propensity Score Matched Analysis

Presenter: Karl-Philipp Rommel

March 04, 2024

Presentation THT 2024

HF Specialist Perspectives and Role in TR Management

Presenter: Ulrich P. Jorde

March 04, 2024

Presentation THT 2024

Updates from Triluminate and TRISCEND II: Perspectives from the FDA Panel

Presenter: Susheel K. Kodali

March 04, 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for February 2024

Shelley Wood

March 01, 2024

News Daily News

FDA Panel Takes a Positive View of TriClip in Tricuspid Regurgitation

Michael O'Riordan

February 13, 2024

News Daily News

FDA Advisors Set to Take on TriClip for TR as TRILUMINATE Questions Loom

Michael O'Riordan

February 09, 2024

News Daily News

FDA Approves First Transcatheter Tricuspid Valve Replacement Device

L.A. McKeown

February 02, 2024

Advertisement

Impact of Tricuspid Transcatheter Edge to Edge Repair on Right Ventricular Function

Diagnostic Imaging and Preparation for T-TEER

Transcatheter Aortic Valve Replacement Reduces Tricuspid Regurgitation Severity at 30 Days – Insights From a Large Academic Medical Center Study

Progression of Mitral Regurgitation Severity After Transcatheter Tricuspid Valve Replacement

Experience-Based Lessons Learned from Real World T-TEER Cases

Young, Low-risk Patients Fare Well With TAVI, but Beware the Bicuspids

First TAVI vs. SAVR randomised trial in younger low-risk patients with severe tricuspid or bicuspid aortic valve stenosis - results from NOTION-2

STS Releases New Risk-Prediction Tools for Emerging Surgical Scenarios

Another Win for TAVI in Patients at Low-to-Intermediate Risk: DEDICATE-DZHK6

FDA Approves TriClip TEER Device for Tricuspid Repair

Evoque and Patisiran: A Tale of Two Regulatory Journeys

First-Ever Performance, Quality Metrics Created for Valvular and Structural Disease

Debating the Role of T-TEER in the Sickest Patients

Right Ventricular-Pulmonary Arterial Coupling in Tricuspid Regurgitation†and Implications of Transcatheter Tricuspid Valve Repair 2013 A Propensity Score Matched Analysis

HF Specialist Perspectives and Role in TR Management

Updates from Triluminate and TRISCEND II: Perspectives from the FDA Panel

TCTMD’s Top 10 Most Popular Stories for February 2024

FDA Panel Takes a Positive View of TriClip in Tricuspid Regurgitation

FDA Advisors Set to Take on TriClip for TR as TRILUMINATE Questions Loom

FDA Approves First Transcatheter Tricuspid Valve Replacement Device

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content